Issued: February 3, 2017
Contact: Linda Miller

OMAHA, Neb. – The Foundation for the Accreditation of Cellular Therapy (FACT) is pleased to announce it has published standards for immune effector cells. The new requirements, included within interim standards for the sixth edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Collection, Processing, and Administration and within the new, first edition FACT Standards for Immune Effector Cells, apply to cells used to modulate an immune response for therapeutic intent, such as dendritic cells, natural killer cells, T cells, and B cells. This includes chimeric antigen receptor T cells (CAR-T cells) and therapeutic vaccines.Read full release



Ask a Peer
FACT Consulting

Accreditation Success Story

Hoxworth Blood Center Apheresis Collection Facility and its Cellular Therapies Division have been accredited by FACT since 2003. The program values their FACT accreditation and the impact it has had on their program’s continuous quality improvement objectives. Read more